Venture capital firm General Catalyst has teamed up with Amazon Web Services (AWS).
The two companies will co-develop and deploy integrated AI-driven products that address needs across predictive and personalized care, interoperability, efficiency, diagnostics and patient engagement. They hope to deliver more personalized care, get insights on population health and disease progression and help translate scientific knowledge into new care models.
"AWS and General Catalyst believe that AI has immense potential to effect [sic] meaningful change in global health care,” AWS CEO Matt Garman said in a press release. “Together, we are taking bold steps to improve patient outcomes and make quality care more accessible to all by embedding AI throughout the care journey."
Partnering with AWS will help General Catalyst offer solutions to healthcare organizations with flexibility and scalability, per a press release. Its portfolio companies include Commure and Aidoc, which will integrate their specialized tech with AWS’ AI and data capabilities.
The companies will also partner with healthcare organizations on cloud migrations and test and refine new solutions in clinical environments. This approach helps make sure that innovations can deliver tangible benefits, the companies argue.
"There's a palpable excitement about the potential of generative AI to transform health care," Steve Davis, president and CEO of Cincinnati Children's Hospital, said in the announcement. The hospital is eager to see how it can improve patient engagement and alleviate administrative burdens, Davis added. “Continuing our work with General Catalyst and AWS can help turn these possibilities into practical realities that can truly move the needle on care quality, operational efficiency, and patient outcomes."
Last fall, AWS announced a collaboration with Philips, focused on providing a cloud-based imaging diagnostics portfolio spanning radiology, pathology, cardiology and AI programs. Meanwhile, General Catalyst has made waves for announcing its intent to buy a health system at the end of 2023. Its Health Assurance Transformation Corporation (HATCo) plans to buy Summa Health for $485 million. HATCo has committed, among other things, to $350 million in capital funding in the first five years to upgrade technologies and infrastructure.